BEAU CARUTHERS: Open Payments
NPI 1477899458 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$241 in 10 payments from 8 companies in 2025. Trend: 2023 $1,730 · 2024 $2,125 · 2025 $241
Food & beverage: $241
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| PFIZER INC. | 2 | $36 |
| BioCryst US Sales Co., LLC | 1 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $28 |
| Lilly USA, LLC | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: ORLADEYO, DUPIXENT, NEFFY, TEZSPIRE, TALTZ, NUCALA, CUVITRU, OCTAGAM IMMUNE GLOBULIN (HUMAN).
Industry payments across FL — which companies pay providers there.
